167 related articles for article (PubMed ID: 2868429)
1. CSF somatostatin-like immunoreactivity in dementia.
Beal MF; Growdon JH; Mazurek MF; Martin JB
Neurology; 1986 Feb; 36(2):294-7. PubMed ID: 2868429
[TBL] [Abstract][Full Text] [Related]
2. Somatostatin-like immunoreactivity and substance-P-like immunoreactivity in the CSF of patients with senile dementia of Alzheimer type, multi-infarct syndrome and communicating hydrocephalus.
Cramer H; Schaudt D; Rissler K; Strubel D; Warter JM; Kuntzmann F
J Neurol; 1985; 232(6):346-51. PubMed ID: 2416886
[TBL] [Abstract][Full Text] [Related]
3. Molecular size distribution of somatostatin-like immunoreactivity in the cerebrospinal fluid of patients with degenerative brain disease.
Rissler K; Cramer H; Schaudt D; Strubel D; Gattaz WF
Neurosci Res; 1986 Feb; 3(3):213-25. PubMed ID: 2871533
[TBL] [Abstract][Full Text] [Related]
4. CSF somatostatin in Alzheimer's disease.
Serby M; Richardson SB; Twente S; Siekierski J; Corwin J; Rotrosen J
Neurobiol Aging; 1984; 5(3):187-9. PubMed ID: 6151123
[TBL] [Abstract][Full Text] [Related]
5. Cerebrospinal fluid somatostatin in delirium.
Koponen H; Stenbäck U; Mattila E; Reinikainen K; Soininen H; Riekkinen PJ
Psychol Med; 1989 Aug; 19(3):605-9. PubMed ID: 2572025
[TBL] [Abstract][Full Text] [Related]
6. Cerebrospinal fluid levels of diazepam-binding inhibitor in neurodegenerative disorders with dementia.
Ferrarese C; Appollonio I; Frigo M; Meregalli S; Piolti R; Tamma F; Frattola L
Neurology; 1990 Apr; 40(4):632-5. PubMed ID: 2138718
[TBL] [Abstract][Full Text] [Related]
7. Comparison of DSIP- (delta sleep-inducing peptide) and P-DSIP-like (phosphorylated) immunoreactivity in cerebrospinal fluid of patients with senile dementia of Alzheimer type, multi-infarct syndrome, communicating hydrocephalus and Parkinson's disease.
Ernst A; Cramer H; Strubel D; Kuntzmann F; Schoenenberger GA
J Neurol; 1987 Oct; 235(1):16-21. PubMed ID: 2448424
[TBL] [Abstract][Full Text] [Related]
8. Ventricular fluid neuropeptides in Parkinson's disease. I. Levels and distribution of somatostatin-like immunoreactivity.
Jost S; Reuner C; Mohadjer M; Mundinger F; Cramer H
Neuropeptides; 1990 Apr; 15(4):219-25. PubMed ID: 1979661
[TBL] [Abstract][Full Text] [Related]
9. Somatostatin and neuropeptide Y in cerebrospinal fluid: correlations with severity of disease and clinical signs in Alzheimer's disease and frontotemporal dementia.
Minthon L; Edvinsson L; Gustafson L
Dement Geriatr Cogn Disord; 1997; 8(4):232-9. PubMed ID: 9213068
[TBL] [Abstract][Full Text] [Related]
10. CSF somatostatin in Alzheimer's disease and major depression: relationship to hypothalamic-pituitary-adrenal axis and clinical measures.
Molchan SE; Hill JL; Martinez RA; Lawlor BA; Mellow AM; Rubinow DR; Bissette G; Nemeroff CB; Sunderland T
Psychoneuroendocrinology; 1993; 18(7):509-19. PubMed ID: 7903467
[TBL] [Abstract][Full Text] [Related]
11. Somatostatin-like immunoreactivity in lumbar cerebrospinal fluid from neurohistologically examined demented patients.
Francis PT; Bowen DM; Neary D; Palo J; Wikstrom J; Olney J
Neurobiol Aging; 1984; 5(3):183-6. PubMed ID: 6151122
[TBL] [Abstract][Full Text] [Related]
12. A correlation study of CSF neuropeptides in Alzheimer's and Parkinson's disease.
Jolkkonen J; Hartikainen P; Soikkeli R; Bissette G; Nemeroff C; Riekkinen P
Neuropeptides; 1991 Jun; 19(2):97-102. PubMed ID: 1682848
[TBL] [Abstract][Full Text] [Related]
13. Molecular forms of somatostatin-like immunoreactivity in the cerebrospinal fluid of patients with senile dementia of the Alzheimer type.
Strittmatter M; Cramer H; Reuner C; Strubel D; Hamann G; Schimrigk K
Biol Psychiatry; 1997 Jun; 41(11):1124-30. PubMed ID: 9146823
[TBL] [Abstract][Full Text] [Related]
14. CSF cyclic nucleotides and somatostatin in Parkinson's disease.
Volicer L; Beal MF; Direnfeld LK; Marquis JK; Albert ML
Neurology; 1986 Jan; 36(1):89-92. PubMed ID: 2867490
[TBL] [Abstract][Full Text] [Related]
15. Somatostatin cerebrospinal fluid levels in dementia.
Molins A; Catalán R; Sahuquillo J; Castellanos JM; Codina A; Galard R
J Neurol; 1991 Jun; 238(3):168-70. PubMed ID: 1678420
[TBL] [Abstract][Full Text] [Related]
16. Somatostatin and cognitive functions in Alzheimer's disease--the relationship of cerebrospinal fluid somatostatin increase with clinical response to tetrahydroaminoacridine.
Alhainen K; Sirviö J; Helkala EL; Reinikainen K; Riekkinen P
Neurosci Lett; 1991 Sep; 130(1):46-8. PubMed ID: 1684233
[TBL] [Abstract][Full Text] [Related]
17. CSF somatostatin-like immunoreactivity in dementia of Parkinson's disease.
Poewe W; Benke T; Karamat E; Schelosky L; Wagner M; Sperk G
J Neurol Neurosurg Psychiatry; 1990 Dec; 53(12):1105-6. PubMed ID: 1981375
[No Abstract] [Full Text] [Related]
18. Cortical somatostatinergic system not affected in Alzheimer's and Parkinson's diseases.
Whitford C; Candy J; Edwardson J; Perry R
J Neurol Sci; 1988 Aug; 86(1):13-8. PubMed ID: 2902199
[TBL] [Abstract][Full Text] [Related]
19. Decreased somatostatin-like immunoreactivity in cerebral cortex and cerebrospinal fluid in Alzheimer's disease.
Reinikainen KJ; Riekkinen PJ; Jolkkonen J; Kosma VM; Soininen H
Brain Res; 1987 Jan; 402(1):103-8. PubMed ID: 3828777
[TBL] [Abstract][Full Text] [Related]
20. Somatostatin and neuropeptide Y immunoreactivity in Parkinson's disease dementia with Alzheimer's changes.
Beal MF; Clevens RA; Mazurek MF
Synapse; 1988; 2(4):463-7. PubMed ID: 2903567
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
